Literature DB >> 12651047

On predictors of sudden cardiac death in hypertrophic cardiomyopathy.

Ali J Marian1.   

Abstract

Entities:  

Mesh：

Year:  2003        PMID： 12651047      PMCID： PMC2887726          DOI： 10.1016/s0735-1097(02)03003-6

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN： 0735-1097            Impact factor:   24.094


× No keyword cloud information.
  41 in total

1.  On genetic and phenotypic variability of hypertrophic cardiomyopathy: nature versus nurture.

Authors:  A J Marian
Journal:  J Am Coll Cardiol       Date:  2001-08       Impact factor: 24.094

Review 2.  The molecular genetic basis for hypertrophic cardiomyopathy.

Authors:  A J Marian; R Roberts
Journal:  J Mol Cell Cardiol       Date:  2001-04       Impact factor: 5.000

3.  Relation between severity of left-ventricular hypertrophy and prognosis in patients with hypertrophic cardiomyopathy.

Authors:  P M Elliott; J R Gimeno Blanes; N G Mahon; J D Poloniecki; W J McKenna
Journal:  Lancet       Date:  2001-02-10       Impact factor: 79.321

4.  Relation between myocyte disarray and outcome in hypertrophic cardiomyopathy.

Authors:  A M Varnava; P M Elliott; N Mahon; M J Davies; W J McKenna
Journal:  Am J Cardiol       Date:  2001-08-01       Impact factor: 2.778

5.  Hypertrophic cardiomyopathy caused by a novel alpha-tropomyosin mutation (V95A) is associated with mild cardiac phenotype, abnormal calcium binding to troponin, abnormal myosin cycling, and poor prognosis.

Authors:  A Karibe; L S Tobacman; J Strand; C Butters; N Back; L L Bachinski; A E Arai; A Ortiz; R Roberts; E Homsher; L Fananapazir
Journal:  Circulation       Date:  2001-01-02       Impact factor: 29.690

6.  Mutations of TTN, encoding the giant muscle filament titin, cause familial dilated cardiomyopathy.

Authors:  Brenda Gerull; Michael Gramlich; John Atherton; Mark McNabb; Karoly Trombitás; Sabine Sasse-Klaassen; J G Seidman; Christine Seidman; Henk Granzier; Siegfried Labeit; Michael Frenneaux; Ludwig Thierfelder
Journal:  Nat Genet       Date:  2002-01-14       Impact factor: 38.330

7.  Simvastatin induces regression of cardiac hypertrophy and fibrosis and improves cardiac function in a transgenic rabbit model of human hypertrophic cardiomyopathy.

Authors:  R Patel; S F Nagueh; N Tsybouleva; M Abdellatif; S Lutucuta; H A Kopelen; M A Quinones; W A Zoghbi; M L Entman; R Roberts; A J Marian
Journal:  Circulation       Date:  2001-07-17       Impact factor: 29.690

8.  Spectrum of clinical phenotypes and gene variants in cardiac myosin-binding protein C mutation carriers with hypertrophic cardiomyopathy.

Authors:  J Erdmann; J Raible; J Maki-Abadi; M Hummel; J Hammann; B Wollnik; E Frantz; E Fleck; R Hetzer; V Regitz-Zagrosek
Journal:  J Am Coll Cardiol       Date:  2001-08       Impact factor: 24.094

9.  Sudden death in hypertrophic cardiomyopathy: identification of high risk patients.

Authors:  P M Elliott; J Poloniecki; S Dickie; S Sharma; L Monserrat; A Varnava; N G Mahon; W J McKenna
Journal:  J Am Coll Cardiol       Date:  2000-12       Impact factor: 24.094

10.  Angiotensin II blockade reverses myocardial fibrosis in a transgenic mouse model of human hypertrophic cardiomyopathy.

Authors:  D S Lim; S Lutucuta; P Bachireddy; K Youker; A Evans; M Entman; R Roberts; A J Marian
Journal:  Circulation       Date:  2001-02-13       Impact factor: 29.690
View more
  7 in total

Review 1.  Assessing the risk of sudden cardiac death in a patient with hypertrophic cardiomyopathy.

Authors:  Michael P Frenneaux
Journal:  Heart       Date:  2004-05       Impact factor: 5.994

Review 2.  Hypertrophic cardiomyopathy: from genetics to treatment.

Authors:  Ali J Marian
Journal:  Eur J Clin Invest       Date:  2010-04       Impact factor: 4.686

3.  3.0 T magnetic resonance myocardial perfusion imaging for semi-quantitative evaluation of coronary microvascular dysfunction in hypertrophic cardiomyopathy.

Authors:  Liang Yin; Hai-Yan Xu; Sui-Sheng Zheng; Ying Zhu; Jiang-Xi Xiao; Wei Zhou; Si-Si Yu; Liang-Geng Gong
Journal:  Int J Cardiovasc Imaging       Date:  2017-06-13       Impact factor: 2.357

Review 4.  Contemporary treatment of hypertrophic cardiomyopathy.

Authors:  Ali J Marian
Journal:  Tex Heart Inst J       Date:  2009

5.  Enhanced active cross-bridges during diastole: molecular pathogenesis of tropomyosin's HCM mutations.

Authors:  Fan Bai; Adam Weis; Aya K Takeda; P Bryant Chase; Masataka Kawai
Journal:  Biophys J       Date:  2011-02-16       Impact factor: 4.033

6.  Lack of salt-inducible kinase 2 (SIK2) prevents the development of cardiac hypertrophy in response to chronic high-salt intake.

Authors:  Sergej Popov; Hiroshi Takemori; Takeshi Tokudome; Yuanjie Mao; Kentaro Otani; Naoki Mochizuki; Nuno Pires; Maria João Pinho; Anders Franco-Cereceda; Lucia Torielli; Mara Ferrandi; Anders Hamsten; Patricio Soares-da-Silva; Per Eriksson; Alejandro M Bertorello; Laura Brion
Journal:  PLoS One       Date:  2014-04-21       Impact factor: 3.240

7.  Microvascular ischemia in hypertrophic cardiomyopathy: new insights from high-resolution combined quantification of perfusion and late gadolinium enhancement.

Authors:  Adriana D M Villa; Eva Sammut; Niloufar Zarinabad; Gerald Carr-White; Jack Lee; Nuno Bettencourt; Reza Razavi; Eike Nagel; Amedeo Chiribiri
Journal:  J Cardiovasc Magn Reson       Date:  2016-01-14       Impact factor: 5.364
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.